Profilo
Dr. Petter Björquist is a Chief Executive Officer at Verigraft AB and a Chief Executive Officer at NovaHep AB. He is on the Board of Directors at ATMP Sweden, Phase Holographic Imaging AB and Stimuliver ApS.
Dr. Björquist was previously employed as a Vice President-Regenerative Medicine by Takara Bio Europe AB.
Posizioni attive di Petter Björquist
| Società | Posizione | Inizio |
|---|---|---|
| PHASE HOLOGRAPHIC IMAGING PHI AB | Direttore/Membro del Consiglio | - |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services Provides stem-cell research for gene therapy of liver diseases | Amministratore Delegato | - |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Amministratore Delegato | 01/02/2014 |
Precedenti posizioni note di Petter Björquist
| Società | Posizione | Fine |
|---|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Corporate Officer/Principal | 01/01/2014 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services Provides stem-cell research for gene therapy of liver diseases | Commercial Services |
Phase Holographic Imaging AB
Phase Holographic Imaging AB BiotechnologyHealth Technology Develops and manufactures imaging microscopes and cell analyzers | Health Technology |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Health Technology |
















